NASDAQ:SEEL

Seelos Therapeutics, Inc.

Stock

USD

Last Close

0.29

30/08 20:00

Market Cap

2.04M

Beta: 1.95

Volume Today

280.72K

Avg: 532.04K

PE Ratio

−2.13

PFCF: −0.34

Overview Analysis Financials Filings people Ownership API Chart Data

locale
United States
market
STOCKS
industry
Biotechnology
website
seelostherapeutics.com
ipo date
Apr 19, 1999

Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.

Excel Tearsheet

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

*Estimate based on analyst consensus